pI: 6.0457 |
Length (AA): 1031 |
MW (Da): 125427 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 1
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 5 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
27 | 804 | 3s5h (A) | 142 | 1010 | 23.00 | 0.63 | 0.97 | 0.663007 | 1.78 |
950 | 1016 | 2avp (A) | 2 | 68 | 9.00 | 0.00007 | 0.01 | 0.255385 | -1.17 |
962 | 1029 | 2pl2 (A) | 155 | 221 | 10.00 | 0.58 | 0.02 | 0.225355 | -0.85 |
16 | 213 | 4tql (A) | 17 | 216 | 12.00 | 0.61 | 0.01 | 0.279452 | -0.02 |
576 | 672 | 2wqh (A) | 17 | 107 | 22.00 | 0.28 | 1 | 0.36715 | -0.66 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | Ring. | Zanghi G |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | intra-erythrocytic - 8 hs, intra-erythrocytic - 24 hs, Oocyst, Male Gametocyte. | Otto TD Zanghi G Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | intra-erythrocytic - 0 hs, intra-erythrocytic - 16 hs, intra-erythrocytic - 32 hs, intra-erythrocytic - 40 hs, intra-erythrocytic - 48 hs, Female Gametocyte. | Otto TD Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | Sporozoite. | Zanghi G |
Lasonder E | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression. |
Otto TD | New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. |
Zanghi G | A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection. |
Ortholog group members (OG5_128360)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G28740 | tetratricopeptide repeat domain-containing protein |
Babesia bovis | BBOV_IV000660 | XBA-binding protein 2, putative |
Brugia malayi | Bm1_33965 | XPA-binding protein 2 |
Candida albicans | CaO19.10411 | RNA splicing |
Candida albicans | CaO19.2893 | RNA splicing |
Caenorhabditis elegans | CELE_C50F2.3 | Protein C50F2.3 |
Cryptosporidium hominis | Chro.70121 | ENSANGP00000023353 |
Cryptosporidium parvum | cgd7_970 | Syf1p. protein with 8 HAT domains |
Dictyostelium discoideum | DDB_G0277977 | TPR-like helical domain-containing protein |
Drosophila melanogaster | Dmel_CG6197 | CG6197 gene product from transcript CG6197-RA |
Echinococcus granulosus | EgrG_000237200 | pre mRNA splicing factor SYF1 |
Entamoeba histolytica | EHI_073290 | hypothetical protein |
Entamoeba histolytica | EHI_073300 | hypothetical protein, conserved |
Echinococcus multilocularis | EmuJ_000237200 | pre mRNA splicing factor SYF1 |
Homo sapiens | ENSG00000076924 | XPA binding protein 2 |
Leishmania braziliensis | LbrM.23.1790 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_231950.1 | hypothetical protein, conserved |
Leishmania infantum | LinJ.23.1950 | hypothetical protein, conserved |
Leishmania major | LmjF.23.1550 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.23.1550 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_08885 | hypothetical protein |
Loa Loa (eye worm) | LOAG_16272 | hypothetical protein |
Loa Loa (eye worm) | LOAG_08304 | XPA-binding protein 2 |
Mus musculus | ENSMUSG00000019470 | XPA binding protein 2 |
Neospora caninum | NCLIV_001120 | XPA-binding protein, putative |
Oryza sativa | 4344088 | Os07g0644300 |
Plasmodium berghei | PBANKA_1450500 | pre-mRNA-splicing factor SYF1, putative |
Plasmodium falciparum | PF3D7_1235900 | pre-mRNA-splicing factor SYF1, putative |
Plasmodium knowlesi | PKNH_1455600 | pre-mRNA-splicing factor SYF1, putative |
Plasmodium vivax | PVX_100745 | pre-mRNA-splicing factor SYF1, putative |
Plasmodium yoelii | PY00967 | Homo sapiens KIAA1177 protein |
Saccharomyces cerevisiae | YDR416W | Syf1p |
Schistosoma japonicum | Sjp_0071210 | Pre-mRNA-splicing factor SYF1, putative |
Schistosoma mansoni | Smp_166240 | hcnp homolog |
Schmidtea mediterranea | mk4.003962.01 | Pre-mRNA-splicing factor SYF1 |
Schmidtea mediterranea | mk4.003190.01 | Pre-mRNA-splicing factor SYF1 |
Schmidtea mediterranea | mk4.011985.00 | Pre-mRNA-splicing factor SYF1 |
Trypanosoma brucei gambiense | Tbg972.5.1840 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.5.1340 | pre-mRNA splicing factor, putative |
Trypanosoma brucei | Tb11.v5.0884 | hypothetical protein, conserved |
Trypanosoma congolense | TcIL3000_0_29970 | HAT (Half-A-TPR) repeats, putative |
Trypanosoma congolense | TcIL3000_5_1380 | HAT (Half-A-TPR) repeats, putative |
Trypanosoma cruzi | TcCLB.509601.40 | pre-mRNA splicing factor, putative |
Trypanosoma cruzi | TcCLB.509767.40 | pre-mRNA splicing factor, putative |
Toxoplasma gondii | TGME49_305240 | XPA binding protein 2 family protein |
Theileria parva | TP01_0087 | adapter protein, putative |
Trichomonas vaginalis | TVAG_258450 | pre-mRNA splicing factor, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.5.1340 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.5.1340 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.5.1340 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.5.1340 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_C50F2.3 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_C50F2.3 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_C50F2.3 | Caenorhabditis elegans | larval lethal | wormbase |
CELE_C50F2.3 | Caenorhabditis elegans | slow growth | wormbase |
CELE_C50F2.3 | Caenorhabditis elegans | sterile | wormbase |
YDR416W | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_1450500 | Plasmodium berghei | Essential | plasmo |
TGME49_305240 | Toxoplasma gondii | Probably essential | sidik |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.